Here are relevant reports on : veterinary-telemedicine-market
-
Asia Pacific Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology), Age (Adults, Pediatrics), End User (Hospitals, ASCs, Payers) - Forecast to 2030
The Asia Pacific telehealth & telemedicine market, valued at US$18.22 billion in 2024, stood at US$21.04 billion in 2025 and is projected to advance at a resilient CAGR of 14.2% from 2024 to 2030, culminating in a forecasted valuation of US$40.83 billion by the end of the period. The growth of the telehealth and telemedicine market in the region is driven by rising demand for remote healthcare delivery, digital health platforms, and virtual care solutions that improve accessibility, efficiency, and cost-effectiveness across diverse population groups.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
IoT in Healthcare Market by Component (Medical Device, Systems & Software, Services, and Connectivity Technology), Application (Telemedicine, Connected Imaging, and Inpatient Monitoring), End User and Region - Global Forecast to 2028
The global IoT in healthcare market size is projected to reach USD 289.2 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 17.8% during the forecast period. This research study outlines the market potential, market dynamics, and major vendors operating in the IoT in Healthcare market. Key and innovative vendors in the the IoT in Healthcare market include Cisco (US), IBM (US), GE Healthcare (US), Microsoft (US), SAP (Germany), Medtronic (Ireland), Royal Philips (Netherlands), Resideo Technologies (US), Securitas (Sweden), Bosch (Germany), Armis (US), Oracle (US), PTC (US), Huawei (Japan), Seimens ( Germany), R-Style Lab (US), HQSoftware (Estonia), Oxagile (US), Softweb Solutions (US), OSP Labs (US), Comarch SA (Poland), Telit (UK), Kore Wireless (US), ScienceSoft (US), Intel (US), AgaMatrix (US), Welch Allyn (US), AliveCor (US), Sensely (US), Clover Health (US).
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Europe Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer) - Forecast to 2030
The Europe telehealth & telemedicine market, valued at US$22.01 billion in 2024, stood at US$24.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$42.04 billion by the end of the period. The growth of the Europe telehealth & telemedicine market is driven by the rising demand for remote healthcare services, increasing adoption of digital health platforms, and expanding broadband and mobile connectivity across the region.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Cellular M2M Market by Service (Connectivity, Professional, and Managed), Application (Asset Tracking and Monitoring, Predictive Maintenance, Telemedicine, and Fleet Management), End User, Organization Size, and Region - Global Forecast to 2025
The Cellular M2M Market is expected to grow from USD 8.3 billion in 2020 to USD 21.0 billion by 2025, at a CAGR of 20.4% during the forecast period. Key players operating in the cellular M2M market include AT&T (US), Verizon (US), T-Mobile (US), Deutsche Telekom (Germany), Orange S.A. (France), Telefonica (Spain), Vodafone (UK), Ericsson (Sweden), Kore Wireless (US), Aeris (US), Arm holdings (UK), China Mobile (China), Infineon (Germany), Thales Group (France), Orbocomm (US), Telit (UK), Giesecke+Devrient (Germany), Cubic Telecom (Ireland), KPN (Netherlands), A1 Digital (Austria), SK Telecom (South Korea), Rogers Communications (Canada), Telenor Connexion (Sweden), Truphone (UK), and 1oT (Estonia). These players have adopted various organic and inorganic strategies to grow in the global cellular M2M market.
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
Telehealth and Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030
The global telehealth and telemedicine market, valued at US$83.62B in 2023, is forecasted to grow at a 11.5% CAGR, reaching US$94.14B by 2024 and US$180.86B by 2030. The telehealth and telemedicine market is experiencing significant growth primarily driven by the growing geriatric and medically underserved (especially rural) populations, the growing prevalence of chronic conditions, the benefits of telehealth & telemedicine given the current shortage of physicians and care personnel, and advancements in telecommunication technologies, and expansion of remote patient monitoring (RPM) systems.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Healthcare IoT Market by Usage (Embedded System, Wireless Network), Product (Monitoring & Notification System, Software), End User (Hospital, Academia, Government), Application (Telemedicine, Clinical Trial, Asset Management)- Global Forecasts to 2019
Emerging markets including Middle East, China, India, Mexico, and Brazil have become attractive destinations for companies engaged in the development and distribution of healthcare IoT products. A number of factors such as growing adoption of cloud-based and mobile healthcare technologies in emerging countries, rising medical tourism due to low cost healthcare facilities, and expansion of healthcare infrastructure across emerging countries (especially in rural areas) are offering high growth opportunities for players active in the global healthcare IoT market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030
The US Telehealth & Telemedicine Market, valued at US$46.10 billion in 2024, stood at US$51.40 billion in 2025 and is projected to advance at a resilient CAGR of 10.2% from 2025 to 2030, culminating in a forecasted valuation of US$83.63 billion by the end of the period. In the US, permanent CMS reimbursement expansions and state-level payment parity laws are driving telehealth growth by securing fair, ongoing reimbursement comparable to in-person care.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Smart Glasses Market by Monocular & Binocular Glasses, Monochrome, Full-color Display, Photochromic, Electrochromic, Polymer-Dispersed Liquid Crystals (PLD), Suspended Particles Device, Gaming, Remote Inspection, Telemedicine - Global Forecast to 2030
The global smart glasses market is expected to grow from USD 19.7 billion by 2026 to USD 4,129.3 million by 2030, at a compound annual growth rate (CAGR) of 29.4% during the forecast period. The key players Meta (US), EssilorLuxottica (France), Seiko Epson Corporation (Japan), Amazon.com, Inc. (US), TCL Electronics Holdings Limited (China), Vuzix (US), Lenovo (China), LUCYD EYEWEAR (US), Xiaomi (China), and Huawei Investment & Holding Co., Ltd. (China).
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) - Forecasts to 2023
The veterinary X-ray market is projected to reach USD 872 million by 2023, at a CAGR of 6.4%. Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the veterinary X-ray market during the forecast period. The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), ROA (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Vaccine (Human, Veterinary (Companion, Livestock)), Type (Organic, Inorganic) - Global Forecast to 2029
The global vaccine adjuvants market, valued at US$0.66 billion in 2023, stood at US$0.70 billion in 2024 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2029, culminating in a forecasted valuation of US$0.96 billion by the end of the period. Growing awareness about livestock health, increasing the adoption of companion animals and developing of therapeutic vaccines for cancer, allergies, and autoimmune disorders are creating lucrative growth opportunities
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
